Lenalidomide with bortezomib and dexamethasone for untreated multiple myeloma (terminated appraisal)

Technology appraisal
Reference number: TA603
Published: 25 September 2019

History

Invitation to participate

Final scope (PDF 224 KB)

Published:

07 December 2018
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 200 KB)

Published:

07 December 2018
Final stakeholder list (PDF 218 KB)

Published:

14 March 2019
Equality impact assessment (Scoping) (PDF 124 KB)

Published:

14 March 2019

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

Draft scope post referral (PDF 317 KB)

Published:

04 September 2018
Draft matrix post referral (PDF 306 KB)

Published:

04 September 2018